Skip to content
Photo of Michael R. Goodman

Michael R. Goodman is an attorney and registered patent agent who advises clients on FDA regulatory compliance and intellectual property needs in the food, medical device, pharmaceutical, biotechnology, dietary supplement, and consumer products industries. Michael assists companies of all sizes in navigating regulatory compliance and developing strategies to avoid delays in their operations. He also prepares, reviews, and negotiates supply and distribution, manufacturing, and advertising agreements, as well as assists with stock and asset purchase agreements.

Before joining Greenberg Traurig, Michael worked as a pharmaceutical consultant focusing on quality assurance and regulatory affairs working with pharmaceutical, medical device, and dietary supplement companies through recalls, audits, filings, and regulatory responses. Michael also took temporary leadership roles in several companies in order to ensure compliance with FDA regulations.

On March 6, 2020, the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) jointly issued seven warning letters to companies making alleged unauthorized claims related to the
Continue Reading FDA and FTC Warn Companies for Unauthorized Coronavirus Disease 2019 (COVID-19) Claims

On Jan. 1, 2019, a new law aiming to limit children’s intake of sugary beverages became effective. California Governor Gavin Newsom signed the “Children’s Meals” law on Sept. 20, 2018,
Continue Reading State of California Passes Law Limiting Sugary Drinks Offered in Children’s Meals